<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04714684</url>
  </required_header>
  <id_info>
    <org_study_id>FITOSTIMOLINE</org_study_id>
    <nct_id>NCT04714684</nct_id>
  </id_info>
  <brief_title>The Role of Fitostimoline Proctogel in Symptoms Relief and Healing in Patients Affected by Anal Fissure</brief_title>
  <official_title>The Role of Fitostimoline Proctogel in Symptoms Relief and Healing in Patients Affected by Anal Fissure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the effectiveness of fitostimoline proctogel in the anal fissure healing and in the&#xD;
      need for invasive interventions (primary endpoints) and in the healing of the fissure&#xD;
      (secondary endpoint) using Fitostimoline in addition to or without other topical devices&#xD;
      available on the market.&#xD;
&#xD;
      Three groups will be established: one for the exclusive use of fitostimoline, the second for&#xD;
      the use of fitostimoline in addition to one of the other topical devices already on the&#xD;
      market and the third group only for the use of other topical therapies.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 10, 2021</start_date>
  <completion_date type="Anticipated">February 10, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 10, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>control of anal fissure symptoms</measure>
    <time_frame>30 days</time_frame>
    <description>pain relief (by using the NRS scale from 0 to 10 (0=absence of pain 10= maximum presence of pain) which should be lower than 3)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>need of invasive treatment</measure>
    <time_frame>30 days</time_frame>
    <description>Anal dilatation, lateral internal sphincterotomy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>anal fissure healing</measure>
    <time_frame>30 days</time_frame>
    <description>no pain (NRS scale &lt; 1, where 0 is absence of pain and 10 is maximum pain), no bleeding</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Fissure in Ano</condition>
  <arm_group>
    <arm_group_label>fitostimoline proctogel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>fitostimoline proctogel + muscle relaxants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>muscle relaxants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fitostimoline proctogel</intervention_name>
    <description>Medical device for topical use for the treatment of fissures</description>
    <arm_group_label>fitostimoline proctogel</arm_group_label>
    <arm_group_label>fitostimoline proctogel + muscle relaxants</arm_group_label>
    <arm_group_label>muscle relaxants</arm_group_label>
    <other_name>muscle relaxant</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fitostimoline proctogel + muscle relaxant</intervention_name>
    <description>medical device for topical use for the treatment of fissures</description>
    <arm_group_label>fitostimoline proctogel</arm_group_label>
    <arm_group_label>fitostimoline proctogel + muscle relaxants</arm_group_label>
    <arm_group_label>muscle relaxants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  None previous therapies for anal fissure&#xD;
&#xD;
          -  Symptomatic anal fistula&#xD;
&#xD;
          -  Signing of informed consent&#xD;
&#xD;
          -  age &gt;18 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients unable to complete the questionnaire and with a legal guardian.&#xD;
&#xD;
          -  Patients with concomitant abscess/fistula&#xD;
&#xD;
          -  Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>November 27, 2020</study_first_submitted>
  <study_first_submitted_qc>January 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 19, 2021</study_first_posted>
  <last_update_submitted>January 15, 2021</last_update_submitted>
  <last_update_submitted_qc>January 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia</investigator_affiliation>
    <investigator_full_name>Gian Luca Baiocchi</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fissure in Ano</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

